SB623-modified stem cells

· SanBio, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SB623-modified stem cells, covering 2020-04-17 to 2020-04-17. Get the full timeline:

Most recent: Clinical Trial Update: Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke [Phase 2]